Professor Lloyd W. Sumner introduces University of Missouri Metabolomics Center. The new center provides leading-edge equipment to gain crucial information on the complex biology of health and disease in plants, animals and humans. The center, located on the second floor of the Christopher S. Bond Life Sciences Center on the MU campus, is one of a few in the country that encourages interdisciplinary research in metabolomics.
By Phillip Sitter | MU Bond Life Sciences Center
For a tiny spore, anthrax holds a lot of danger and promise.
If you found yourself wondering about more than its safety in the lab, we have a answers to a few persistent questions.
What makes anthrax dangerous, and how does it spread? How common are infections of it in nature? If we have antibiotics that already treat it, beyond finding new and better ones why study the organism?
Bovine slayer and bio-weapon
Anthrax bacteria are highly resilient organisms. Like only a few other bacteria in nature, they produce spores with protein-shelled casings that lay dormant in soil for long periods of time, waiting to be taken in by grazing animals like cattle and sheep.
Once they enter the nutrient-rich environment of an animal’s bloodstream — exactly how the bacteria gets there after entering an animal’s mouth is unknown — spores germinate inside the white blood cells that absorb them. As anthrax reproduces rapidly inside its host, it releases toxins that quickly kill the infected animal. That sometimes happens in just a matter of hours according to farmers’ accounts, said George Stewart, Bond Life Sciences Center scientist, medical bacteriologist, McKee Professor of Microbial Pathogenesis and chair of Veterinary Pathobiology at MU.
When infected animals die the bacteria are exposed to oxygen in air that penetrates the decomposing body and new spores escape as the dead host decays. The newly-produced spores are deposited back into the soil, where they wait in a state of suspended animation for as long as it takes to be ingested by another grazing animal, sometimes decades to a hundred years.
Sporadic, natural outbreaks of anthrax can happen almost anywhere in the world except Antarctica, as the spores have been found to exist worldwide, Stewart said. In the United States, outbreaks in cattle and bison usually happen in the Plains and West in states like Colorado and Wyoming — anywhere that cattle or sheep have been raised or their wildlife equivalents graze, lending to the descriptor from Stewart of “anthrax belt” for the states stretching from Texas to the Dakotas.
During the Cold War, the U.S. and the Soviet Union, among others, were attracted to anthrax for their respective biological weapons programs because of the hardiness of the organism and high lethality rates of untreated gastrointestinal and, especially, pulmonary anthrax infections in humans. Today, Americans’ are probably most familiar with anthrax from the mailing attacks of 2001, when letters containing weaponized anthrax spores were delivered to the offices of media outlets and politicians, infecting 22 people and killing five.
Hero in a half-life shell?
Despite their grim reputation, anthrax spores hold a lot of potential for Stewart.
The outermost layer of the protein-shell structure of a spore holds particular interest — how it’s made, what proteins it’s composed of and the function of those proteins. Studying it could not only help find future anthrax vaccines and therapies, but also be used for other applications.
Scientists have coated spores of a close biological relative of anthrax, Bacillus thuringiensis, with plant growth-promoting and anti-insect enzymes and other proteins to treat crops. Its durable structure in the form of the spore’s protein shell attach to these enzymes and remain longer in the environment, making them more effective, Stewart said.
This long biological half-life even presents potential for bio-remediation work — using natural organisms to cleanse the environment of toxins and pollutants. In the case of B. thuringiensis, this might include cleaning up soil from the herbicide atrazine and the notorious pollutant dioxin, a by-product of various industrial processes including incineration, smelting and the production of paper pulp and some herbicides and pesticides.
According to collective findings of the National Institutes of Health and Environmental Protection Agency and others, atrazine is probably not a human carcinogen but can cause genetic damage in animals and is still acutely toxic to people at high enough levels. According to the World Health Organization (WHO), dioxin causes cancer and other ill human ailments.
Pollutants that contaminate soil can eventually leech into groundwater and also enter the food supply through grazing animals. That makes organisms adapted to living in soil like B. thuringiensis perfect candidates as potential carriers of agents used to clean up soil pollutants like atrazine and dioxin.
However, Stewart said that there is too much public stigma to use anthrax for similar applications, “which is too bad because Bacillus anthracis actually works a little better in these applications.”
Rethinking the anthrax image
So is anthrax a dastardly bio-villain or a misunderstood hero?
The truth is neither. Anthrax bacterium is just another living thing.
As a predator of other living things, needing to feed to survive and reproduce, it goes about its life cycle without any conscious agenda. It has no malice, and unlike a wolf, shark or hawk it doesn’t have a brain so it doesn’t even have instinct, only genetic code to mindlessly live by.
How we interact with anthrax is largely dependent upon us humans.
We have the vaccines to prevent it and antibiotics to treat it if it makes us sick. After that, we can harness and modify anthrax’s natural power for ill as a weapon, or maybe to do some good in the environment. So long as we have the technology to study and manipulate organisms like anthrax, the potential for both scenarios will always be there.
Meanwhile, at MU Stewart will continue to study anthrax, searching for its secrets in order to better understand it, to better serve the rest of us.
Next time you squirt mustard on a sandwich on enjoy wasabi with your sushi, you can thank a battle between broccoli and butterflies. Just ask Bond LSC biologist Chris Pires, our latest scientist in our Decoding Science audio series that runs on KBIA, 91.3 FM.
Pires has studied the process of co-evolution between plants in the order Brassica — including broccoli, caulifower and kale — and insects in the cabbage butterfly family to prove that this back and forth helped make both into what they are today.
The safety behind studying deadly disease
By Phillip Sitter | MU Bond Life Sciences Center
You’ve seen it before in the movies.
Sweaty scientists put on their full-body, spacesuit-like get-ups to stave off a potentially extinction-level outbreak and at least one scientist invariably gets infected with the deadly agent of disease.
While popular culture propagates this sense of peril, in reality bio-containment labs are designed with safety in mind.
“People tend to think bio-containment facilities are dangerous, mostly from movies I think, but the history is actually spectacular,” said George Stewart, a medical bacteriologist, a Bond Life Sciences Center scientist, McKee Professor of Microbial Pathogenesis and Chair of Veterinary Pathobiology.
For Stewart — whose lab works on the basic science behind anthrax — no one is “under the gun because of big outbreaks, not with the pressure you see in movies.”
But one type of pressure is an important part of bio-containment lab safety. Air pressure differences maintain certain labs at lower pressure compared to the rooms and hallways around them, ensuring that air will only flow in toward a lab and not out, keeping any airborne pathogens trapped inside.
“They know if everything is done properly, it’s perfectly safe for them and even safer for everyone else [outside a lab],” Stewart said of the safety features, procedures and systems of bio-containment lab safety in place at facilities like those at the Bond LSC and elsewhere at MU.
Stewart said he is vaccinated against anthrax. “Whether I have protective immunity or not, I don’t know.”
“Almost like you were working underwater”
The powerful capabilities of anthrax and other lethal pathogens call for particular safety precautions for scientists.
Stewart looks like he’s straight out of the movie Contagion when donning the full-body suit for his more dangerous research in a Bio-Safety Level (BSL) 3 facility at MU’s Laboratory for Infectious Disease Research (LIDR). In the trees on the eastern fringes of campus, the specialized building is where he and other researchers study diseases animals can transmit to humans, including plague, Brucella, tularemia and Q fever, and mosquito-borne diseases like dengue, chikungunya and now Zika virus. The safety protocols and systems at a BSL-3 lab like the LIDR facility Stewart described reflect the likely transmission by aerosols of the human pathogens inside.
After passing through security access to the building and the labs inside, Stewart enters an ante room off of a hallway. The air pressure in this room and the lab beyond it is such that air will only flow in toward the lab, and not out and away.
Anything that goes into the lab only leaves if it is autoclaved, disinfected in a steel machine using pressurized steam that “essentially kills everything, even heat-resistant spores,” so that means Stewart changes clothes, removes his watch, phone and any other personal items.
Next come layered scrubs and a water-proof Tyvek suit with booties and a hood that cover everything but his hands and face. Two layers of gloves take care of his hands, but shielding his face is a bit more technical.
A plastic face cover with a Tyvek hood shrouds over Stewart’s shoulders. Inside, a pump fills the hood with positively-pressured filtered air – this has the inverse effect of the negative pressure of the rooms and keeps air flowing out away from his face and not toward it.
Everything inside the lab and the building is about redundancies like that. A final safety measure is that all work on pathogens take place in bio-safety hoods – HEPA-filtered cabinets.
Stewart said it can be difficult to hear with the air filter systems blowing, so every move by researchers is calculated and announced. Colleagues take their time in handing off equipment to one another, so as to avoid torn gloves.
It’s “almost like you were working underwater as two divers,” Stewart said about working in the BSL-3 lab with a colleague.
“Everything is orchestrated in a very intentional way.”
Only dangerous when dry
Anthrax isn’t always lethal, so the scene is quite different inside a BSL-2 lab at Bond LSC where Stewart studies non-virulent strains.
BSL-2 labs study infectious agents that can cause disease in humans, but are usually treatable. Researchers only need lab coats, gloves and eye protection in these labs and all waste must be autoclaved. Here anthrax and other colonies of organisms are stacked in covered Petri dishes and handled without any Tyvek or air pumps.
The Anthrax bacterium researched here is missing a specific plasmid, a DNA molecule essential for virulence that protects the anthrax bacteria from white blood cells that attack them.
On top of that, all samples in this lab are wet, and anthrax spores are only dangerous as aerosols when dry. Before 2001, Stewart said virulent strains of anthrax were only labeled BSL-2 agents for this reason.
The anthrax letter attacks that year not only changed some of the organism’s lab classifications, but also interest in it. Prior to 2001, Stewart said there was not a lot of funding available for anthrax-focused researchers, a small and tight-knit community. Even though the attacks did spur an increased investment of government money into the field at the time for defense against anthrax as a bio-weapon agent, almost 15 years later Stewart said that funding is more or less back at pre-2001 levels, “perhaps marginally better.”
There are now only a handful of anthrax-dedicated labs in the U.S., Stewart said, trying to name them off as he counted his fingers. The Bond LSC has not had any lab higher than a BSL-2 plus for years now, not since the BSL-3 research moved to LIDR, Stewart said.
Several local residents called when LIDR was under construction and asked questions and voiced concerns about the facility and the work to be done there, Stewart recalled. However, Stewart said he and his colleagues gave the callers honest answers, and he has not heard of any pushback since.
Stewart sees bio-containment labs as positive technological achievements in the study of disease – without them, many advances in treatment would never have been possible. In terms of the work done at facilities at MU and in the Bond LSC, Stewart said “we have the facilities, we have the equipment, we have the training,” to ensure the safety of researchers inside the labs, and even more so everyone else on the outside.
Anthrax is not contagious and responds well to antibiotics, despite concerns in the scientific community Stewart shared that there is a possibility antibiotic resistance could be intentionally engineered into anthrax.
Stewart could only think of a couple of cases when lab workers got infected with the organism through mishaps, and those were at USAMRIID – the United States Army Medical Research Institute for Infectious Disease at Fort Detrick, Maryland – when anthrax was produced there in very large quantities for research of it as a bio-weapon during the Cold War.
When you spend a lot of your time working with potentially lethal pathogens though, what do you tell your doctor when you come in with flu-like symptoms? Stewart said that not only does he and any of his colleagues disclose to their doctor the organisms that they work with, but doctors at MU already know exactly what organisms are being researched inside the LIDR labs. As a precautionary measure for their own well-being in case accidental infection did occur in a lab after all, Stewart or another colleague working with anthrax who turned up sick would receive antibiotics just to be safe – “there are standard operating procedures for everything.”
He does not want to make light of the dangerous organisms he works with, but inside the BSL-3 facility at LIDR, Stewart said that breathing in HEPA-filtered air all day there does do wonders for his hay fever.
Stewart couldn’t help but share a chuckle with that one. Laughter might be the most un-containable thing in nature.
Gene therapy treating the neurodegenerative disease, SMARD1, shows promising results in mice studies.
Monir Shababi was confident her experiments treating a rare genetic disease would yield positive results before she even ran them.
Scientists had success with a similar degenerative neuromuscular disease, so she had every expectation their strategy would work just as well in her mice.
“I was expecting to get the same results,” said Shababi, an assistant research profession in Christian Lorson’s lab at the University of Missouri Bond Life Sciences Center. Shababi studies spinal muscular atrophy with respiratory disease type 1, or SMARD1.
The treatment worked, but not without a few surprises.
Her findings, published in Molecular Therapy, a journal by Nature Publishing Group, are one of the first to show how gene therapy can effectively reverse SMARD1 symptoms in mice.
In patients, SMARD1 is considered such a rare genetic disorder by the U.S. National Library of Medicine that no one knows how frequently the disease occurs. It’s only when babies develop the first symptom—trouble breathing–that pediatricians screen for SMARD1.
Shortly after diagnosis, muscle weakness appears in the hands and feet before spreading inwards to the rest of the body. The average life expectancy for a child diagnosed with SMARD1 is 13 months. There is currently no effective treatment.
Since the neuromuscular disease is caused by a recessive gene, SMARD1 comes as a shock to the parents, who are carriers but do not show signs of the illness, Shababi said. This genetic defect prevents cells from making a particular protein that scientists suspect is vital to replication and protein production.
The hereditary nature of the disease has a silver lining, though. Because SMARD1 is a caused by a single pair of faulty genes and not multiple ones, it is a prime candidate for gene therapy that could restore the missing protein and reverse the disease.
To do that, Shababi set up a dose-response study using a tiny virus to carry the genetic instructions for making the missing protein. She injected newborn mice with a low dose of the virus, a high dose, or a placebo with no virus at all.
Injecting at different doses allowed her to ask which dose worked better, Shababi said.
According to the previous research, a higher dose should have resulted in a more effective treatment.
“So I thought a higher dose was going to work better,” Shababi said.
Instead, the high dose had a toxic effect. Mice given more of the virus died sooner than untreated mice. Meanwhile, mice given a low dose of the gene therapy lived longest. They regained muscle function and strength in both the forearms and the hind limbs and became more active.
In fact, some of them survived long enough to mate and produce offspring.
Initially, Shababi housed her SMARD1 mice in the same cage as their mothers so that the moms could intervene if the sick pups become too feeble to feed themselves. When the male pups became well, their moms became pregnant.
“That was another surprise,” Shababi said. “That was when I knew I had to separate them.”
In another twist, Shababi discovered that the route of injection also mattered.
To get the treatment across the blood-brain barrier and to the spinal cord, Shababi used a special type of injection that passes through the skull and the ventricles of the brain, and into the spine.
This was no easy task.
The newborn mice were no larger than a gummy bear. To perform the delicate work, Shababi — who has written a chapter in a gene delivery textbook about this procedure — had to craft special needles with tips fine enough for this injection. She added food coloring to the injection solution so she could tell when it had reached its intended destination.
“After half an hour, you will see it in the spinal cord,” Shababi said. “The blue line in the spine: that’s how you can monitor the accuracy of the injection.”
Unfortunately, repeated injections in the mice caused hydrocephaly, or swelling in the brain.
“They get a dome-shaped head,” Shababi explained.
The swelling happened in all three treatment groups, but most frequently in the group that received a high dose of viral gene therapy. This reinforced the finding that while a low dose was beneficial, a high dose was even more harmful than no treatment at all. It’s unclear why.
The Lorson lab plans to continue studying SMARD1 and this treatment, in particular, how changing the delivery routes for gene therapy can improve outcomes in treating SMARD1.
“It’s not as simple as replacing the gene,” Lorson said. “It comes down to the delivery.”
Injections in the brains of mice are meant to mimic spinal cord injections in humans, but intravenous delivery could be another option. However, intravenous injections, which travel through the blood stream and to the entire body, might cause off-target effects that could interfere with the effectiveness of the treatment.
Once researchers better understand how to optimize dosing and delivery on the cellular and organismal level, the therapy can move closer to clinical trials, Lorson said.
Even though gene therapy for SMARD1 is still in its early stages, he said he was optimistic that developing treatments for rare genetic diseases is no longer the impossible task it seemed even ten years ago.
Spinal muscular atrophy (SMA) is a prime example of a recent success, Lorson pointed out. In the last six years, gene therapy for that disease has moved from the research lab to Phase I clinical trials.
“While it feels like a long time for any patient and their families,” Lorson reassured, “things are moving at a breakneck pace.”
The study, “Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent,” was published in Molecular Therapy, a journal published by Nature Publishing Group. This work was supported by a MU Research Board Grant (C.L.L.); MU College of Veterinary Medicine Faculty Research Grant (M.S.); the SMA Foundation (C.P.K.); National Institute of Health/National Institute of Neurological Disorders and Stroke grants; and the Missouri Spinal Cord Injury Research Program (M.L.G.).
What makes you crave?
Bond LSC’s Matt Will explores the science behind food cravings in his research on mice.
Erik Potter from Mizzou Creative’s Eureka! Podcast tells us more in this month’s segment. Hear more of their science stories at news.missouri.edu/eureka
New outreach program teaches CAFNR students to make plant science knowledge accessible to a younger audience
Written by Stephen Schmidt | Science Writer in the College of Agriculture, Food and Natural Resources
Although abundant light was shining through the windows, it was the quiet before the storm. Andrew Ludwig, a University of Missouri sophomore majoring in plant sciences, surveyed the small tables and chairs spread out before him in the laboratory of the Benton STEM Elementary School on a recent Monday afternoon. He sifted through his notes. He was ready, even though it was his first time stepping foot in the building — and he was about to talk to a crowd of students spanning from the first to the fifth grade.
“I’m just going to try to stay enthused about everything because I’ve talked to some of my friends who are education majors and the big thing with conveying information to them is just being enthusiastic about it,” Ludwig said about his strategy on the “How Do Flowers Drink?” presentation he was about to give with fellow MU student Michael Gardner.
“I think the key is keeping them moving along, keeping them interested, because as soon as you lose their attention, they’re going to do whatever they want to do, so it’s going to be keeping things moving along at a pace that they’re still getting it, but that they’re not bored out of their minds,” added Gardner, who is a fifth-year graduate student specializing in plant stress biology. “We’re talking about water transport in a plant, which is a concept you can spend a semester on in a college-level course and still not be considered an expert on the topic.”
Both Ludwig and Gardner are a part of the team at the Bond Life Sciences Center lab of Melissa Mitchum, an associate professor in the Division of Plant Sciences. It was Mitchum who was able to launch the new “It’s All About Plants” series this spring with the Benton Elementary Science Club thanks to the science outreach portion of a new National Science Foundation grant that will further delve into a deeper understanding of the interactions between plants and parasitic nematodes she received in August and a partnership with the MU College of Education’s ReSTEM Institute, MU Office of Undergraduate Research and Columbia Public Schools.
The end result is a program that fosters learning of all varieties: The elementary students learn about plants, while the college students learn how to take complex ideas and break them down to a more accessible level. Furthermore, the program pairs undergraduate students such as Ludwig with graduate students such as Gardner and principal investigator mentors from across campus — involving the existing NSF-funded initiative Freshman Research in Plant Sciences (FRIPS) and the Students for the Advancement of Plant Pathology (SAPP) in the process.
“I think it’s a challenge for all of us who have advanced degrees to really think about where we were long ago and bring the concepts down to a basic level,” Mitchum said, “but I think it’s very important for us to be able to communicate our science at that level to really get the kids excited about research.”
She added that the program “really reinforces the concept of engagement and active learning.” In particular, it reinforces hands-on learning through a variety of activities. “I think that makes a big difference in learning,” said Mitchum, who will have sat with the children for five of the 10 presentations that started on Feb. 22. “I think that’s one of the reasons why I’m such a strong advocate of undergraduate research and getting in a lab and learning how to work in a lab. The same thing applies here. When the kids are doing experiments in the science club, they’re going to retain that information a lot more.”
School’s in session
“Class! Class! Class!”
“Yes! Yes! Yes!”
With those loud words reverberating through the room Ludwig had the attention of those before him — for a moment, anyway. The chatter had quieted down as he began to explain the main activity of the day, which would involve carnation flowers and six solutions of household items (sugar, salt, baking soda, vinegar, soda and food coloring) mixed with water in the same-sized cups – and one scenario with just water.
With the help of several volunteer MU students (whose hours are coordinated by Mitchum’s co-PI, Deanna Lankford, a research associate in the College of Education), the assignment was to pour 100 millimeters into each one of the cups.
The cups were then labeled with the name of the solution. This procedure was repeated three times. The white carnations were then cut to the height of the cup and placed in the water as a discussion ensued on what solutions would help the plant (besides plain water) and which ones would hurt.
Afterwards through the help of a video, the class was introduced to the idea of setting up controls and variables. The one variable, in this case, was the solution. All other factors (such as flower height, flower type, cup size and amount of liquid) were controlled, Ludwig explained. “We use the control to compare our other variables,” he said.
A moment later, Ludwig posed a question to the class: “Raise your hand if you think putting the flower in food coloring is going to change the color of the flower.” A collection of hands sprouted upward.
“We have some flowers that we put in the dye yesterday,” Ludwig continued, as he unveiled carnations that had white petals either tinged in red or blue to pass around to the class.
“I was right!”
“I knew it!”
“Do we get to keep them?”
A white carnation begins to show traces of blue food coloring in its petals after sitting in a solution with food coloring and water for a short period of time.
Following a brief video showing a similar experiment relating to celery and food coloring, Gardner explained the phenomenon to the class: “The plant is basically a big straw, so as the water evaporates up the plant, it pulls more water with it and then the food coloring too, so it gets to the very top of the plant, either the leaves of a tree or the top of a flower, and when it gets there the water will be able to evaporate, but the food dye can’t so that’s why your flowers are turning blue or red, OK?”
The food coloring portion of the afternoon turned out to be the top highlight for many of the participants. When asked about all of the projects he had worked on during the spring, Amahdrion Bradshaw, a second grader, proclaimed that “the funnest one was about dying the plants.”
Haily Korn, a fellow second grader, agreed, saying that her favorite part of the program is when you “do fun experiments” and that her favorite experiment was “when you get to dye stuff.”
A perfect fit
Lankford and the ReSTEM Institute formed the Benton Elementary Science Club, which meets one afternoon every week during the school year, seven years ago — the same time Benton officially became a part of the STEM (Science, Technology, Engineering and Mathematics) program.
“The science club has allowed our students to continue to expand their understanding of a variety of science topics through hands-on experiences after school,” said Heather McCullar, a STEM specialist who works at Benton. “The kids always leave club excited to share what they have learned with their families.”
Over the years, Lankford has helped many principal investigators with the education portion of their grants. When Mitchum asked her about getting involved with an existing partnership, Lankford immediately thought about the science club with its previously established learning format.
“Melissa said ‘I need help with this.’ And I said ‘Great, let’s talk,’” Lankford said, “And we did and we came up with the idea and it has been wonderful. I really like the fact that we have mentors and mentees doing the presentations.”
Under Mitchum’s direction, a series of meetings were set up with mentors and mentees last fall to develop the curriculum and lesson plans that would form the backbone of the course. Given that the grant is funded for a total of three years, the plan is to continue to teach the “It’s All About Plants” program, which has been well-received by students and school administrators alike, at Benton next spring.
Besides Mitchum, the other PI mentors from CAFNR who have taken part in the program are Gary Stacey, Curators Professor of Plant Sciences; Lee Miller, assistant professor of plant sciences; Xi Xiong, assistant professor of plant sciences; Walter Gassmann, professor of plant sciences; John Boyer, Distinguished Research Professor of Plant Sciences; Harley Naumann, assistant professor of plant sciences; Kevin Bradley, associate professor of plant sciences; Heidi Appel, senior research scientist, plant sciences; Jack Schultz, professor of plant sciences and director of the Bond Life Sciences Center; and Scott Peck, associate professor of biochemistry. PI mentors from the College of Arts and Science Division of Biological Sciences included Paula McSteen, Chris Pires, and Mannie Liscum.
The CAFNR students who took part in the science club series planning also recently hosted an outreach booth on t the Science Sleuth event on “Plants and Microbes” the MU campus April 16. In addition, Mitchum gave a talk at the Exploring Life Sciences symposium at the Bond Life Science’s Center recent Missouri Life Sciences Week.
Furthermore, the end goal is to take all of the lessons that are being created and turn them into a booklet that is easily accessible for teachers in Columbia Public Schools, and beyond, by posting the material online.
In the meantime, the lessons are being molded by the interactions of CAFNR students and those at Benton.
“You have some students who can’t write their names yet, and other people who know everything we’re trying to tell them before we start,” Gardner said, afterwards, referring to the beginning of the class when a student at the front of the room recited a brief and succinct view of a plant’s water transport system. “Apparently his grandma told him all of this stuff already. So yeah that was definitely a challenge that I think we did OK at it.”
“I think it’s really great for everyone involved from the elementary school students who are getting to learn about specific topics from people who are very well informed about it to undergraduate and graduate students who are getting a wider arrange of presentation skills,” Ludwig added. “You can get locked in your head about your research. It’s good to be reminded that the knowledge we gain through research also has a real-world application and that part of the scientific process is sharing.”
It’s a challenge that Mitchum said could serve as a benefit to anyone in the scientific community.
“It’s not easy for us to do many times,” Mitchum said of breaking complex idea down into something easy enough for a child to understand, or even an average adult. “It takes practice. So. It’s something we have to learn. Science communication is very important these days. Especially when we talk about what we’re doing in a lab, it’s very molecular, very cellular, but we have to find a way to make it relevant.”
She added that programs such as this one show children that not all scientists have “crazy hair with the goggles and lab coat. They see ‘Oh, these guys are just like everyday people.’ This is a realistic career for them.”
Would Amahdrion be interested in such a career path?
“Nope,” he said. “I want to be a basketball player.”
Still, when given the choice of attending the science club sessions or just going home after school, he has a quick reply: “Spending extra time at school because you learn more.”
Work on HIV capsid proteins earns prestigious retrivology award
Science is all about structure in the work of Anna Gres.
For the past four years, she’s looked closely at one HIV protein to figure out its shape in order to stop the virus.
“Capsid protein is extremely important during the HIV life cycle. About 1,500 copies of it come together to form the protective core around the viral genome,” said Gres, a graduate student in the lab of Bond Life Sciences Center’s Stefan Sarafianos and a Mizzou Ph.D. candidate in chemistry. “So, if you are able to somehow disrupt the interactions between the proteins or make them different, the virus loses its infectivity.”
Gres takes her work on this protein to a national stage next month when she speaks at the Retroviruses meeting at Cold Spring Harbor Laboratory — one of the most prestigious international conference on retroviruses — as the recipient of the 2016 Uta Von Schwedler prize. The prize recognizes the accomplishments of one distinguished graduate student as they complete their thesis.
HIV capsid protein has been studied for almost 30 years, but it’s been tricky to get a precise depiction of what it looks like. Gres uses X-ray crystallography to essentially capture the protein in all its 3-D glory. This method gives scientists the higher resolution picture to study the molecular structure of capsid protein. Her work allows the Sarafianos lab and others to study how it interacts and connects with other capsid proteins and the host protein factors of the cell HIV is trying to take over.
“In the past scientists had been splitting the capsid protein in two halves and crystallizing them separately. Another approach was to introduce several mutations to make it more stable,” Gres said. “You would think that it shouldn’t really matter if we have a few mutations, but the protein behaves in such a way that even slight changes result in subtly different interactions that are enough for the virus to lose its infectivity. We were able to crystallize the native protein without any mutations and that should give us more accurate picture.”
Now that the Sarafianos lab and Gres have a good idea of what that native protein looks like, they’ve moved on to other mutated versions of the protein that impair virus infectivity. This could give them insight into how scientists can stop HIV.
“Many labs reported numerous mutations in the capsid protein over the past 25 years that either increase or decrease the stability of the core, which often results in a noninfectious virus,” she said. “Right now we are interested in seeing what structural changes accompany these mutations and how they can affect the overall stability of the core.”
By Bobby Remis | MU Bond Life Sciences Center
In the years to come, climate change and population growth will drastically alter the world around us, impacting farmland and the way we grow food.
New research from an interdisciplinary team at the University of Missouri is hoping to curb the decrease in food production due to climate change by studying the roots of corn and understanding its growth in these intense conditions.
Scott C. Peck — an investigator at the Bond Life Sciences Center — joins an interdisciplinary team that plans to study corn root growth in
drought conditions. The National Science Foundation (NSF) recently awarded them a $4.2 million grant to spend four years developing drought-tolerant corn varieties in an effort to sustain the 9 billion people estimated worldwide by 2050.
The interdisciplinary team is comprised of seven co-primary investigators from four MU colleges as well as the USDA-ARS.
Read the full release from Mizzou News.
How unruly data led MU scientists to discover a new microbiome
By Roger Meissen | MU Bond Life Sciences Center
It’s a strange place to call home, but seminal fluid offers the perfect environment for particular types of bacteria.
Researchers at MU’s Bond Life Sciences Center recently identified new bacteria that thrive here.
“It’s a new microbiome that hasn’t been looked at before,” said Cheryl Rosenfeld, a Bond LSC investigator and corresponding author on the study. “Resident bacteria can help us or be harmful, but one we found called P. acnes is a very important from the standpoint of men. It can cause chronic prostatitis that results in prostate cancer. We’re speculating that the seminal vesicles could be a reservoir for this bacteria and when it spreads it can cause disease.”
A place to call home
From the gut to the skin and everywhere in between, bacterial colonies can both help and hurt the animals or humans they live in.
Seminal fluid offers an attractive microbiome — a niche environment where specific bacteria flourish and impact their hosts. Not only is this component of semen chockfull of sugars that bacteria eat, it offers a warm, protected atmosphere.
“Imagine a pond where bacteria live — it’s wet it’s warm and there’s food there — that’s what this is, except it’s inside your body,” said Rosenfeld. “Depending on where they live, these bacteria can influence our cells, produce hormones that replicate our own hormones, but can also consume our sugars and metabolize them or even cause disease.”
Rosenfeld’s team wasn’t trying to find the perfect vacation spot for a family of bacteria. They initially wanted to know what bacteria in seminal fluid might mean for offspring of the mice they studied.
“We were looking at the epigenetic effects — the impact the father has on the offspring’s disease risk — but what we saw in the data led us to focus more on the effects this bacterium, P. acnes, has on the male itself,” Rosenfeld said. “We were thinking more about effect on offspring and female reproduction — we weren’t even considering the effect the bacteria that live in this fluid could have on the male — but this could be one of the more fascinating findings.”
But, how do you figure out what might live in this unique ecosystem and whether it’s harmful?
First, her team found a way to extract seminal fluid without contamination from potential bacteria in the urinary tract.
“We gowned up just like for surgery and we had to extract the fluid directly from the seminal vesicles to avoid contamination,” said Angela Javurek, primary author on the study and recent MU graduate. “You only have a certain amount of time to collect the fluid because it hardens like glue.”
Once they obtained these samples, they turned to a DNA approach, sequencing it using MU’s DNA Core.
They compared it to bacteria in fecal samples of the same mice to see if bacteria in seminal fluid were unique. They also compared samples from normal mice and ones where estrogen receptor genes were removed.
The difference in the data
It sounds daunting to sort and compare millions of DNA sequences, right? But, the right approach can make all the difference.
“A lot of it looks pretty boring, but bioinformatics allow us to decipher large amounts of data that can otherwise be almost incomprehensible,” said Scott Givan, the associate director of the Informatics Research Core Facility (IRCF) that specializes in complicated analysis of data. “Here we compared seminal fluid bacterial DNA samples to publicly available databases that come from other large experiments and found a few sequences that no one else has discovered or at least characterized, so we’re in completely new territory.”
The seminal microbiome continued to stand out when compared to mouse poop, revealing 593 unique bacteria.
One of the most important was P. acnes, a bacteria known to cause chronic prostatitis that can lead to prostate cancer in man and mouse. It was abundant in the seminal fluid, and even more so when estrogen receptor genes were present.
“We’re essentially doing a lot of counting, especially across treatments to see if particular bacteria species are more common than others,” said Bill Spollen, a lead bioinformatics analyst at the IRCF. “The premise is that the more abundant a species is, the more often we’ll see its DNA sequence and we can start making some inferences to how it could be influencing its environment.”
Although this discovery excites Rosenfeld, much is unknown about how this new microbiome might affect males and their offspring.
“We do have this bacteria that can affect the male mouse’s health, that of his partner and his offspring,” Rosenfeld said. “But we’ve been studying microbiology for a long time and we still find bacteria within our own bodies that nobody has seen before. That blows my mind.”
The study, “Discovery of a Novel Seminal Fluid Microbiome and Influence of Estrogen Receptor Alpha Genetic Status,” recently was published in Scientific Reports, a journal published by Nature.